Pharmaceuticals, Technology · medium ·
The enterprise AI shift is creating a pharma R&D coordination-layer shortage
Pharmaceutical companies are making substantial multi-year, multi-hundred-million-dollar commitments to enterprise-wide AI platforms. This strategic pivot moves beyond fragmented, point solutions to integrate AI intelligence across the entire drug discovery, development, and commercialisation lifecycles, aiming for unified data ecosystems and accelerated efficiency.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.
Part of the Technology Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.